Sign Up
SB 35 South Dakota Senate · 2025 Regular Session

modify substances listed on the controlled substances schedule and to declare an emergency.

This bill proposes to update the list of controlled substances in South Dakota by modifying the schedules under which certain drugs are classified. It directly affects state law enforcement, healthcare providers, and individuals by changing how specific substances are regulated and monitored. The legislation includes provisions to declare an emergency, which allows for expedited legislative action on these substance control measures. This change aims to align state regulations with current drug trends and federal standards.
Bill status signed all 5 stages cleared
Introduction
Jan 2025
Committee Review
Feb 2025
Senate Passage
Jan 2025
House Passage
Feb 2025
Signed into Law
Feb 2025
Introduced Jan 14, 2025 Signed Feb 19, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced → Enrolled · 4 edits · Feb 7, 2025
MODERATE
This bill amends South Dakota's controlled substances schedules to update and expand the list of regulated substances, particularly focusing on various fentanyl analogs and other synthetic opioids. The changes add numerous specific chemical compounds and derivatives to Schedule I, including detailed definitions of fentanyl analogs based on structural modifications. This expansion aims to close regulatory gaps by ensuring that new or modified versions of dangerous synthetic opioids remain controlled under state law.
Scope change
The bill significantly expands the scope of controlled substances from a limited list of specific compounds to include broad categories of fentanyl analogs and additional synthetic opioids, hallucinogens, and related substances.
SCOPE

Added 17 new specific opium derivatives and opiates to Schedule I, including compounds like 3-Methylfentanyl, Brorphine, and Zipeprol.

Added 14 new hallucinogenic substances to Schedule I, including various tryptamine derivatives and amphetamine analogs.

DEFINITION

Added comprehensive definition of fentanyl analogs covering any substituted derivatives structurally related to fentanyl through specific chemical modifications.

REQUIREMENT

Modified existing controlled substance schedules to include broader chemical categories and structural variations rather than just specific named compounds.

Floor votes · Senate Jan 23, 2025 · House Feb 6, 2025

How they voted

34–0
Passed · 1 other
Total votes 35
Jan 23, 2025
D Democratic3
3 Yea
100% Yea
R Republican32
31 Yea 1
96% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
12
Key actions
7
Committee
2
Feb 19, 2025
Signed into law
Signed by the Governor on 2025-02-19 S.J. 288
executive
Feb 10, 2025
Lower · Passed
Signed by the Speaker H.J. 246
lower
Feb 7, 2025
Lower · Passed
Signed by the President S.J. 212
lower
Feb 6, 2025
Lower · Passed
House of Representatives Do Pass , Passed, YEAS 65, NAYS 3 H.J. 216
lower
Feb 5, 2025
Lower · Passed
Judiciary Do Pass , Passed, YEAS 12, NAYS 0
lower
Jan 24, 2025
Introduced
First read in House and referred to H.J. 113
lower
Jan 23, 2025
Upper · Passed
Senate Do Pass , Passed, YEAS 34, NAYS 0 S.J. 82
upper
Jan 22, 2025
Upper · Passed
Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0
upper
Jan 14, 2025
Introduced
First read in Senate and referred to S.J. 11
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.